Product apis-proteases

Home > products > apis> proteases

Catalog	name	Description	price
R-C-2572	Metolazone CAS:17560-51-9	Metolazone(SR-720-22)is primarily used to treat congestive heart failure and high blood pressure.	price>
R-C-2573	Delanzomib (CEP-18770) CAS:847499-27-8	Delanzomib(CEP-18770)is a potent and orally active chymotrypsin-like activity of the proteasome inhibitor with an IC50 of 3.8nM.Delanzomib inhibits NF-κB activity,induces cancer cell apoptotic,and has strong antiangiogenic and anti-cancer activities.	price>
R-C-2643	SPK-601 CAS:1096687-52-3	SPK-601(LMV-601)is an inhibitor of the phosphatidylcholine-specific phospholipase C(PC-PLC).SPK-601 also can be used as an antimicrobial agent.	price>
R-C-2716	FASN-IN-1 CAS:1808260-84-5	FASN-IN-1 is a fatty acid synthase(FASN)inhibitor extracted from patent WO2015134790A1,compound 56.	price>
R-C-2731	ABT-046 CAS:1031336-60-3	ABT-046 is a potent,selective,and orally efficacious acyl CoA:diacylglycerol acyltransferase 1(DGAT-1)inhibitor(IC50=8nM).	price>
R-C-2735	Telotristat CAS：1033805-28-5	Telotristat(LP-778902)is the acid form of Telotristat ethyl,and the active metabolite of LX1606(Telotristat etiprate),which is an orally bioavailable, small-molecule,tryptophan hydroxylase(TPH)inhibitor and serotonin synthesis inhibitor with potential antiserotonergic activity.	price>
R-C-2736	Dafadine-A CAS:1065506-69-5	Dafadine-A,an analog of dafadine, is a novel inhibitor of DAF-9 cytochrome P450 in the nematode Caenorhabditis elegans; also inhibits the mammalian ortholog of DAF-9(CYP27A1).	price>
R-C-2739	PF-04620110 CAS:1109276-89-2	PF-04620110 is a potent,selective and orally bioavailable diglyceride acyltransferase-1(DGAT-1)inhibitor with an IC50 of 19nM.	price>
R-C-2743	AZD7687 CAS:1166827-44-6	AZD7687 is a potent,selective,reversible and orally active diacylglycerol acyltransferase 1(DGAT1)inhibitor with an IC50 of 80nM for human DGAT1. AZD7687 can be used for type 2 diabetes mellitus and obesity research.	price>
R-C-2744	AP-III-a4 CAS:2070014-95-6	ENOblock(AP-III-a4)is a novel small molecule which is the first,nonsubstrate analogue that directly binds to enolase and inhibits its activity(IC50=0.576uM);inhibit cancer cell metastasis in vivo.	price>

...